Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells

Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells

Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1) was first described as an auto-antigen over-expressed in Sjögren's syndrome and in scleroderma patients. SSSCA1 has been linked to mitosis and centromere association and as a potential marker candidate in diverse solid cancers. Here we charact...

書誌詳細
主要な著者:	Perdreau-Dahl, H, Progida, C, Barfeld, SJ, Guldsten, H, Thiede, B, Arntzen, M, Bakke, O, Mills, IG, Krauss, S, Morth, JP
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature 2020

類似資料

An Evolutionary Perspective on the Origin, Conservation and Binding Partner Acquisition of Tankyrases
著者:: Sven T. Sowa, 等
出版事項: (2022-11-01)

Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.
著者:: Y Jeffrey Chiang, 等
出版事項: (2008-07-01)

Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
著者:: Estefania Martino-Echarri, 等
出版事項: (2016-01-01)

Regenerating Gene Protein as a Novel Autoantigen in the Pathogenesis of Sjögren’s Syndrome
著者:: Takashi Fujimoto, 等
出版事項: (2015-12-01)

Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma
著者:: Ulku Kucuk, 等
出版事項: (2018-01-01)

Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation
著者:: Amit Bhardwaj, 等
出版事項: (2017-12-01)

The magnesium transporter A is activated by cardiolipin and is highly sensitive to free magnesium in vitro
著者:: Saranya Subramani, 等
出版事項: (2016-01-01)

Three’s Company: Coexistence of Silicosis, Scleroderma, and Sjogren Syndrome in a Single Patient
著者:: Alexis Ziebelman, 等
出版事項: (2022-01-01)

Identification of the mouse beta'-COP Golgi component as a spermatocyte autoantigen in scleroderma and mapping of its gene Copb2 to mouse chromosome 9.
著者:: Tarsounas, M, 等
出版事項: (1999)

Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines
著者:: Line Mygland, 等
出版事項: (2021-07-01)

The orthologue of Sjögren's syndrome nuclear autoantigen 1 (SSNA1) in Trypanosoma brucei is an immunogenic self-assembling molecule.
著者:: Helen P Price, 等
出版事項: (2012-01-01)

The N-terminal cytoplasmic region of NCBE displays features of an intrinsic disordered structure and represents a novel target for specific drug screening
著者:: Kaare eBjerregaard-Andersen, 等
出版事項: (2013-11-01)

Tankyrase inhibition sensitizes cells to CDK4 blockade.
著者:: Miguel Foronda, 等
出版事項: (2019-01-01)

Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques
著者:: M.G. Bottone, 等
出版事項: (2012-01-01)

The nature of autoantigens
著者:: Ivan M. Roitt, 等
出版事項: (1987-01-01)

Immunogenicity of autoantigens
著者:: Keller Andreas, 等
出版事項: (2011-07-01)

Multiple E3 ligases control tankyrase stability and function
著者:: Jerome Perrard, 等
出版事項: (2023-11-01)

Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
著者:: Wenqi Wang, 等
出版事項: (2015-10-01)

Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity.
著者:: Nina Marie Pedersen, 等
出版事項: (2016-01-01)

Novel binding mode of a potent and selective tankyrase inhibitor.
著者:: Hakan Gunaydin, 等
出版事項: (2012-01-01)

Tankyrase represses autoinflammation through the attenuation of TLR2 signaling
著者:: Yoshinori Matsumoto, 等
出版事項: (2022-04-01)

Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death.
著者:: Pan Ye, 等
出版事項: (2018-09-01)

Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren’s syndrome
著者:: Kathrine Skarstein, 等
出版事項: (2019-11-01)

Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities
著者:: Esteban Zamudio-Martinez, 等
出版事項: (2021-04-01)

Tankyrases Promote Homologous Recombination and Check Point Activation in Response to DSBs.
著者:: Zita Nagy, 等
出版事項: (2016-02-01)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
著者:: Vasiliki Koulouri, 等
出版事項: (2023-01-01)

Scleroderma with Nodular Scleroderma
著者:: Chutika Srisuttiyakorn, 等
出版事項: (2016-11-01)

3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
著者:: Luned M Badder, 等
出版事項: (2020-01-01)

Scleroderma and scleroderma-like syndromes
著者:: Katarzyna Romanowska-Próchnicka, 等
出版事項: (2024-06-01)

Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling
著者:: Nan Li, 等
出版事項: (2019-09-01)

Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors
著者:: Frankie Poon, 等
出版事項: (2024-10-01)

Interferon and autoantigens: intersection in autoimmunity
著者:: Brendan Antiochos, 等
出版事項: (2023-05-01)

Autoantigens and Autoantibodies in Multiple Sclerosis
著者:: Abbas Mirshafiey, 等
出版事項: (2013-12-01)

Identification of multiple, distinct cicatritial pemphigoid autoantigens.
著者:: Rao, S, 等
出版事項: (1996)

The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
著者:: Jens Henrik Norum, 等
出版事項: (2018-01-01)

Corrigendum: Scleroderma and Scleroderma-like syndromes
著者:: Katarzyna Romanowska-Próchnicka, 等
出版事項: (2024-07-01)

Paraneoplastic scleroderma or neoplasia secondary to scleroderma
著者:: Alexandru Arvunescu, 等
出版事項: (2019-12-01)

Identification of Novel Native Autoantigens in Rheumatoid Arthritis
著者:: Thomas B. G. Poulsen, 等
出版事項: (2020-05-01)

Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
著者:: Jiaoyuan Jia, 等
出版事項: (2017-01-01)

The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain
著者:: Sven T. Sowa, 等
出版事項: (2022-03-01)